Treceți offline cu aplicația Player FM !
Season 2 - Ep. 4: Current indications for CRT - The polypill for CVD prevention
Manage episode 407315173 series 3559418
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
- Cardiology This Week: A concise summary of recent studies
- Current indications for Cardiac Resynchronisation Therapy
- The polypill for cardiovascular disease prevention
- Snapshots
Host: Perry Elliott
Guests: Carlos Aguiar, Cecilia Linde, Valentin Fuster, Stephan Achenbach
Want to watch that episode? Go to: https://esc365.escardio.org/event/1139
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Valentin Fuster and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic.
Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics.
Cecilia Linde has declared to have potential conflicts of interest to report: research grants to institutions; Swedish Heart Lung Foundation, Swedish Academy of Science, Stockholm County Council, Roche Diagnostics. Speaker honoria: AstraZeneca, Medtronic, Impulse Dynamics, Vifor, Novartis, Boehringer Ingelheim, MSD, Bayer Advisory Board, AstraZeneca (continuity study), Medtronic (Women and CRT), Medtronic Implementation of CRT and ICD. DSMB: UCS Uppsala ABC Study.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
47 episoade
Manage episode 407315173 series 3559418
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
- Cardiology This Week: A concise summary of recent studies
- Current indications for Cardiac Resynchronisation Therapy
- The polypill for cardiovascular disease prevention
- Snapshots
Host: Perry Elliott
Guests: Carlos Aguiar, Cecilia Linde, Valentin Fuster, Stephan Achenbach
Want to watch that episode? Go to: https://esc365.escardio.org/event/1139
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Valentin Fuster and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic.
Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics.
Cecilia Linde has declared to have potential conflicts of interest to report: research grants to institutions; Swedish Heart Lung Foundation, Swedish Academy of Science, Stockholm County Council, Roche Diagnostics. Speaker honoria: AstraZeneca, Medtronic, Impulse Dynamics, Vifor, Novartis, Boehringer Ingelheim, MSD, Bayer Advisory Board, AstraZeneca (continuity study), Medtronic (Women and CRT), Medtronic Implementation of CRT and ICD. DSMB: UCS Uppsala ABC Study.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
47 episoade
Toate episoadele
×Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.